September 2011
Intermediate to advanced
784 pages
28h 47m
English
Tax and Accounting Considerations
In matters of style, swim with the current. In matters of principle, stand like a rock.
—Thomas Jefferson
Teva Pharmaceutical Industries, a manufacturer and distributor of generic drugs, completed its takeover of Ivax Corp for $7.4 billion in early 2006 to become the world's largest manufacturer of generic drugs. For Teva, based in Israel, and Ivax, headquartered in Miami, the merger eliminated a large competitor and created a distribution chain that spans 50 countries.
To broaden the appeal of the proposed merger, Teva offered Ivax shareholders the option to receive for each of their shares either 0.8471 ...
Read now
Unlock full access